ML
Therapeutic Areas
Intuitive Surgical Pipeline
| Drug | Indication | Phase |
|---|---|---|
| da Vinci 5 | Multi-quadrant Minimally Invasive Surgery | Development |
| da Vinci SP (Single-Port) | Single-incision/access procedures (Urologic, Transoral) | Commercial |
| Ion | Peripheral Lung Biopsy | Commercial |
| da Vinci Xi | Multi-quadrant Minimally Invasive Surgery | Commercial |
| da Vinci X | Multi-quadrant Minimally Invasive Surgery | Commercial |
Leadership Team at Intuitive Surgical
GS
Gary S. Guthart
Chief Executive Officer
JE
Jamie E. Samath
Chief Financial Officer
DR
Dave Rosa
Chief Executive Officer, Intuitive Ventures
MR
Megan Rosengarten
President, Commercial
BM
Brian Miller
Chief Financial Officer, Intuitive Foundation
BD
Bob DeSantis
Executive Vice President & Chief Product Officer
MJ
Mark Johnson
Executive Vice President & Chief Technology Officer
CD
Calvin Darling
Senior Vice President, Investor Relations
LJ
Luis Jose
Vice President, Global Business Services & CIO
MJ
Myriam J. Curet
Executive Vice President & Chief Medical Officer